Acute respiratory distress syndrome: fibrosis fast and furious

References

• Suchyta MR, Clemmer TP, Elliot CG, Orme JF Jr, Weaver LK. The adult respiratory distress syndrome: a report of survival and modifying factors. Chest 1992; 101:1074–1079.
   Google Scholar
• Zilberberg MD, Epstein SK. Acute lung injury in the medi-cal ICU: comorbid conditions, age, etiology and hospital outcome. Am. J. Resp. Crit. Care Med. 1998; 157:1159–1164.
   PubMed Web of Science ®Google Scholar
• Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndro-me (ARDS): 1983-1993. JAMA 1995; 273: 306–309.
   PubMed Web of Science ®Google Scholar
• Abel SJC, Finney SJ, Brett SJ, Keogh BE, Morgan CJ, Evans TW. Reduced mortality in association with the acute respir-atory distress syndrome (ARDS). Thorax 1998; 53: 292–294.
   PubMed Web of Science ®Google Scholar
• Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1988; 138: 720–723.
   PubMed Web of Science ®Google Scholar
• Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung inj-ury: predictors of mortality. Am. J. Resp. Crit. Care Med. 1995; 152:1818–1824.
   PubMedGoogle Scholar
• Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordina-tion. Am. J. Resp. Crit. Care Med. 1994; 149: 818–824.
   PubMed Web of Science ®Google Scholar
• Marshall RP, Bellingan G, Webb S, et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am. J. Respir. Crit. Care Med. 2000; 162: 1783–1788.
   PubMed Web of Science ®Google Scholar
• Hudson LD. What happens to survivors of the adult respir-atory distress syndrome? Chest 1994; 105(3 Suppl): 123S–126S.
   Google Scholar
• The Acute Respiratory Distress Syndrome Clinical Network: Ventilation with lower tidal volumes as compared with tra-ditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 2000; 342: 1301–1308.
   PubMed Web of Science ®Google Scholar
• Ware LB, Matthay MA. The acute respiratory distress syn-drome. N. Engl. J. Med. 2000; 342: 1334–1349.
   PubMed Web of Science ®Google Scholar
• Hasleton PS, Roberts TE. Adult respiratory distress syndr-ome - an update. Histopathology 1999; 34: 285–294.
   PubMed Web of Science ®Google Scholar
• Griffiths MJD, Evans TW. Adult respiratory distress syndr-ome. In: Brewis RAL, Corrin B, Geddes DM, Gibson GJ (eds), Respiratory Medicine. 2nd edn. London: W.B. Saunders, 1995: pp. 605–629.
   Google Scholar
• Martin C, Papazian L, Payan MJ, Saux P. Gown F. Pulmon-ary fibrosis correlates with outcome in adult respiratory distress syndrome: a study in mechanically ventilated pat-ients. Chest 1995; 107: 196–200.
   Google Scholar
• Bellingan G. The early fibrotic response in acute lung injury and the role of steroids. In: Galley H (ed), Critical Care. 2. Respiratory Failure. London: BMJ Publishers, 1999: pp. 37–51.
   Google Scholar
• Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am. Rev. Resp. Dis. 1985; 132: 485–489.
   PubMed Web of Science ®Google Scholar
• Raghu G, Striker u, Hudson LD, Striker GE. Extracellular matrix in normal and fibrotic human lungs. Am. Rev. Resp. Dis. 1985; 131: 281–289.
   PubMed Web of Science ®Google Scholar
• Deheinzelin D, Jatene FB, Saldiva PHN, Brentani RR. Up-regulation of collagen messenger RNA expression occurs immediately after lung damage. Chest 1997; 112:1184–1188.
   PubMed Web of Science ®Google Scholar
• Liebler JM, Qu Z, Buckner B, Powers MR, Rosenbaum JT. Fibroproliferation and mast cells in the acute respiratory distress syndrome. Thorax 1998; 53: 823–829.
   Google Scholar
• Harrison NK, Laurent GJ, Evans TW. Transpulmonary gra-dient of type III procollagen peptides: acute effects of car-dio-pulmonary bypass. Intensive Care Med. 1992; 18: 290–292.
   Google Scholar
• Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III procollagen peptide in the adult respiratory distress synd-rome: association of increased peptide levels in broncho-alveolar lavage fluid with increased risk for death. Ann. Intern. Med. 1995; 12:17–23.
   Google Scholar
• Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Procollagen types I and III aminoterminal propeptide lev-els during acute respiratory distress syndrome and in res-ponse to methylprednisolone treatment. Am. J. Resp. Crit. Care Med. 1998; 158:1432–1441.
   Google Scholar
• Chestnutt AN, Matthay MA, Tibayan FA, Clark JG. Early detection of type III procollagen peptide in acute lung in-jury: pathogenetic and prognostic significance. Am. J. Resp. Crit. Care Med. 1997; 156: 840–845.
   PubMed Web of Science ®Google Scholar
• Entzian P, Huckstadt A, Kreipe H, Barth J. Determination of serum concentration of type III procollagen peptide in mechanically ventilated patients. Pronounced augmented concentrations in the adult respiratory distress syndrome. Am. Rev. Resp. Dis. 1990; 140: 1079–1082.
   Google Scholar
• Pittet JF, MacKersie RC, Martin TR, Matthay MA. Biologi-cal markers of acute lung injury: prognostic and pathologi-cal significance. Am. J. Resp. Crit. Care Med. 1997;155: 1187–1205.
   PubMed Web of Science ®Google Scholar
• Lee CT, Fein AM, Lippman M, Hotzmann H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N. Engl. J. Med. 1981; 304:192–196.
   PubMed Web of Science ®Google Scholar
• Shasby DM, Fox RB, Harada RN, Repine JE. Reduction of the oedema of hyperoxic lung injury by granulocyte deple-tion. J. Appl. Physiol. 1982; 52: 1237–1244.
   PubMed Web of Science ®Google Scholar
• Chollet-Martin S, Jourdain B, Gilbert C, Elbim C, Chastre J, Gougerot-Pocidalo MA. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am. J. Resp. Crit. Care Med. 1996; 154: 594–601.
   Google Scholar
• Donnelly SC, Haslett C. Cellular mechanisms of acute lung injury: implications for future treatment in the adult respir-atory distress syndrome. Thorax 1992; 47: 260–263.
   PubMed Web of Science ®Google Scholar
• Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. Hu-man mast cell chymase and leukocyte elastase release late-nt transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 1995; 270: 4689–4696.
   Google Scholar
• Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmo-nary type II-like epithelial cells. J. Biol. Chem. 1991; 266: 9912–9918.
   Google Scholar
• Donnelly SC, Hiram N, Bucala R. Macrophage Migration Inhibitory Factor (MIF), Inflammation and Acute Lung In-jury, chapter in: Acute Lung Injury: From Inflammation to Repair. IOS Press 2000. Bellingan, GJ and Laurent, GJ, eds.: pp. 37–42.
   Google Scholar
• Khalil N, O'Connor RN, Flanders KC, Unruth H. TGF-b1, but not TGF-b2 or TGF-b3, is differentially present in epi-thelial cells of advanced pulmonary fibrosis: an immuno-histochemical study. Am. J. Respir. Cell Mol. Biol. 1996; 14: 131–138.
   PubMed Web of Science ®Google Scholar
• Standiford TJ, Kunkel SL, Basha MA, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest. 1990; 86: 1945–1953.
   PubMed Web of Science ®Google Scholar
• Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LA. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001; 280: L298–L305.
   PubMedGoogle Scholar
• Liebler JM, Qu ZH, Buckner B, Powers MP, Rosenbaum JT. Fibroproliferation and mast cells in the acute respiratory distress syndrome. Thorax 1998; 53: 823–829.
   Google Scholar
• Meduri GU, Kohler G, Headley S, Tolley E, Stenz F, Postle-thwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108:1303–1314.
   Google Scholar
• Bellingan GJ. Mechanisms of inflammation. In: Bellingan, GJ and Laurent, GJ (eds.) Acute Lung Injury: From Inflamm-ation to Repair. IOS Press 2000: pp. 7–14.
   Google Scholar
• Madtes DK, Rubenfeld G, Klima LD, Milberg JA, Steinberg KP, Martin TR. Elevated transforming growth factor-alpha levels in bronchoalveolavage fluid of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1998; 158: 424–430.
   PubMed Web of Science ®Google Scholar
• Gleizes P-E, Munger JS, Nunes I, et al. TGF-b latency: biol-ogical significance and mechanisms of action. Stem Cells 1997; 15: 190–197.
   Google Scholar
• Coker RK, Laurent GJ, Jeffery PK, du Bois RM, Black CM, McAnulty RJ. Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal fibrotic hum-an lung. Thorax 2001; 56: 549–556.
   Google Scholar
• Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am. J. Respir. Crit. Care Med. 2000; 161: 1999–2004.
   Google Scholar
• Marshall RP, Webb S, Bellingan G, et al. Angiotensin con-verting enzyme I/D polymorphism in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2000; 161: A209.
   Google Scholar
• Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer J- M. Matrix metalloproteinases and TIMPs in acute respira-tory distress syndrome. Am. J. Respir. Crit. Care Med. 996; 154: 346–352.
   Google Scholar
• Tetley TD. Neutrophil- and macrophage-derived proteases in chronic obstructive pulmonary disease and acute respi-ratory distress syndrome. In: Bellingan, GJ and Laurent, GJ (eds.) Acute Lung Injury: From Inflammation to Repair. IOS Press 2000: pp. 7–14.
   Google Scholar
• Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies [State of the Art]. Am. J. Respir. Crit. Care Med. 1998; 157: 294–330.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechani-cal ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized contr-olled trial. JAMA 1999; 282: 54–61.
   PubMed Web of Science ®Google Scholar
• Held HD, Boettcher S, Hamann L, Uhlig S. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kB and is blocked by steroids. Am. J. Respir. Crit. Care Med. 2001; 163: 711–716.
   PubMed Web of Science ®Google Scholar
• Butt R, Bishop JE. Mechanical load enhances the stimulat-ory effects of serum growth factors on cardiac fibroblast synthesis. J. Mol. Cell. Cardiol. 1997; 29:1141–1151.
   PubMed Web of Science ®Google Scholar
• Ziesche R, Block L-H. Interferon Gamma-1b: mechanisms of action, preclinical studies and clinical experience. In: King Jr., TE (ed.) New Approaches to Managing Idiopathic Pulmo-nary Fibrosis. American Thoracic Society Press 2000: pp. 36–43.
   Google Scholar
• Keerthisingam CB, Jenkins RG, Harrison NK, et al. Cyclo-oxygenase-2 deficiency results in a loss of the anti-prolif-erative response to transforming growth factor-beta in hu-man fibrotic lung fibroblasts and promotes bleomycin-ind-uced pulmonary fibrosis in mice. Am. J. Pathol. 2001; 158: 1411–1422.
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Araki K, Vesin C, et al. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lym-phocytic and fibrosing alveolitis. A mouse model of progr-essive pulmonary fibrosis. J. Clin. Invest. 1995; 96: 250–259.
   PubMed Web of Science ®Google Scholar
• Munger JS, Huang X, Kawakatsu H, et al. The integrin al-pha v beta 6 binds and activates latent TGF beta 1: a mecha-nism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96: 319–328.
   PubMed Web of Science ®Google Scholar
• Dunsmore SE, Roes J, Chua F, Segal AW, Mutsaers SE, Laurent GJ. Evidence that neutrophil elastase-deficient mice are resistant to bleomycin-induced fibrosis. Chest 2001; 120 (1 Suppl): 355-36S.
   Google Scholar
• Ashbaugh DG, Maier RV. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treat-ment. Arch. Surg. 1985; 120: 530–535.
   PubMed Web of Science ®Google Scholar
• Weigelt JA, Norcross JF, Borman KR, Snyder III WH. Early steroid therapy for respiratory failure. Arch. Surg. 1985; 120: 536–540.
   Google Scholar
• Schein RM, Bergman R, Marcial EH, et al. Complement act-ivation and corticosteroids therapy in the development of the adult respiratory distress syndrome. Chest 1987; 91: 850–854.
   PubMed Web of Science ®Google Scholar
• Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mor-tality in patients with septic shock. Am. Rev. Respir. Dis. 1988; 138: 62–68.
   PubMed Web of Science ®Google Scholar
• Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987; 92:1032–1036.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Luce JM, Sprung CL, et al. High-dose cortico-steroids in patients with the adult respiratory distress syn-drome. N. Engl. J. Med. 1987; 317: 1565–1570.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper KV Jr (1991) Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 100: 943–952.
   Google Scholar
• Meduri GU, Chinn AJ, Leeper KV, et al. Corticosteroid resc-ue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest 1994; 105: 1516–1527.
   Google Scholar
• Meduri GU, Headley S, Tolley E, Shelby M, Stentz F, Postlethwaite A. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 1995; 108: 1315–1325.
   PubMed Web of Science ®Google Scholar
• Meduri GU, Headley AS, Golden E, et al. Effect of prolong-ed methylprednisolone therapy in unresolving acute respir-atory distress syndrome: a randomized controlled trial. JAMA 1998; 280:159–165.
   PubMed Web of Science ®Google Scholar
• Late Steroid Rescue Study (LaSRS). Acute Respiratory Dist-ress Syndrome Clinical Network (ARDSNET). Available at http://www.ardsnet.org. Accessed January 2002.
   Google Scholar
• O'Leary EC, Evans GE, Zuckerman SH. In vivo dexamethas-one effects on neutrophil effector functions in a rat model of acute lung injury. Inflammation 1997; 21: 597–608.
   PubMed Web of Science ®Google Scholar
• O'Leary EC, Marder P, Zuckerman SH. Glucocorticoid eff-ects in an endotoxin-induced rat pulmonary inflammation model: differential effects on neutrophil influx, integrin ex-pression and inflammatory mediators. Am. J. Respir. Cell. Mol. Biol. 1996; 15: 97–106.
   PubMed Web of Science ®Google Scholar
• Yi ES, Remick DG, Lim Y, et al. The intratracheal adminis-tration of endotoxin: X. Dexamethsone downregulates neu-trophil emigration and cytokine expression in vivo. Inflam-mation 1996; 20: 165–175.
   Google Scholar
• Borg T, Gerdin B, Modig J. Prophylactic and delayed treat-ment with high-dose methylprednisolone in a porcine model of early ARDS induced by endotoxaemia. Acta Anaesthesiol. Scand. 1985; 29: 831–845.
   Google Scholar
• Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idi-opathic pulmonary fibrosis. N. Engl. J. Med. 1999; 341:1264–1269.
   Google Scholar
• Panos RJ, Bak PM, Simonet WS, Rubin JS, Smith U. Intra-tracheal instillation of keratinocyte growth factor reduces hyperoxia-induced mortality in rats. J. Clin. Invest. 1995; 96: 2026–2033.
   Google Scholar